REGENEREX PHARMA, INC. Interest Costs Incurred
REGENEREX PHARMA, INC. reported Interest Costs Incurred of $7.00 thousand for the 9-month period ending 2022-12-31, per its 10-Q filed 2023-01-24.
Discontinued › Expense Statement › Operating Expenses
us-gaap:InterestCostsIncurred · last filed 2023-01-24
- 2022-12-31: Interest Costs Incurred 9 month $7.00K.
| Period end | Interest Costs Incurred 9 month |
|---|---|
| 2022-12-31 | $7.00K 10-Q · filed 2023-01-24 |